Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Ultrasound for Botulinum Toxin Subscapularis Muscle Injection Guidance in Spastic Hemiplegic Shoulder Pain

NCT03621423 is registered in ClinicalTrials.gov with Loewenstein Hospital as lead sponsor.

NCT NCT03621423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03621423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Ultrasound for Botulinum Toxin Subscapularis Muscle Injection Guidance in Spastic Hemiplegic Shoulder Pain
Lead sponsor
Loewenstein Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
November 1, 2018
Completion date
August 1, 2020
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemiplegia, spastic